Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-19

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

The FDA approved Unichem Pharmaceuticals' original ANDA for a generic fixed-dose combination tablet of irbesartan and hydrochlorothiazide. It is indicated for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)